Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Int J Lab Hematol ; 43(5): 1093-1103, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33844466

ABSTRACT

INTRODUCTION: The lymphoid enhancer factor 1 (LEF1) is a DNA-binding transcription factor that functions in the Wnt signaling pathway. Increased LEF1 activity is associated with progression of several types of cancer including leukemia. Here, we investigated LEF1 isoform expression and genomic variations in acute lymphoblastic leukemia (ALL). METHODS: LEF1 isoform expression was evaluated by quantitative real-time PCR in 87 newly diagnosed childhood ALL patients and controls. Moreover, Western blot analysis was performed for detection of LEF1 expression and the hotspot region of LEF1 was screened by deep sequencing. RESULTS: The LEF1 mRNA expression of B cell ALL patients was higher than the controls (LEF1-total P = .011, LEF1-long P = .026). Moreover, B-ALL samples showing higher total LEF1 expression had significantly shorter relapse-free survival (P = .008) and overall survival (P = .011). Although full-length LEF1 expression was similar to the controls in T-ALL, 50% (n = 15) of the ALL patients had increased full-length LEF1 protein expression. Imbalance between short- and full-length LEF1 isoforms may lead to cell survival in ALL. Beside the LEF1 activation, LEF1 gene variations were rarely observed in our cohort. CONCLUSION: The results indicate that the Wnt pathway may have a pathogenic function in a group of ALL patients and high LEF1-total expression might be a marker for shorter relapse-free survival time in B cell ALL.


Subject(s)
Lymphoid Enhancer-Binding Factor 1/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Case-Control Studies , Cell Line, Tumor , Child , Child, Preschool , Female , Gene Expression Regulation, Leukemic , Genetic Variation , Humans , Male , Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis , Prognosis , Protein Isoforms/genetics
2.
Cardiol Young ; 25(4): 705-11, 2015 Apr.
Article in English | MEDLINE | ID: mdl-24912974

ABSTRACT

It has been shown that mitochondrial deoxyribo nucleic acid mutations may play an important role in the development of cardiomyopathy, and various types of cardiomyopathy can be attributed to disturbed mitochondrial oxidative energy metabolism. Several studies have described many mutations in mitochondrial genes encoding for subunits of respiratory chain complexes. Thus, recent studies confirm that pathologic mitochondrial deoxyribo nucleic acid mutations are a major reason of diseases and determining them by next-generation sequencing will improve our understanding of dysregulation of heart development. To analyse mitochondrial deoxyribo nucleic acid mutations, the entire mitochondrial deoxyribo nucleic acid was amplified in two overlapping polymerase chain reaction fragments from the cardiac tissue of the 22 patients with congenital heart disease, undergoing cardiac surgery. Mitochondrial deoxyribo nucleic acid was deep sequenced by next-generation sequencing. A total of 13 novel mitochondrial deoxyribo nucleic acid mutations were identified in nine patients. Of the patients, three have novel mutations together with reported cardiomyopathy mutations. In all, 65 mutations were found, and 13 of them were unreported. This study represents the most comprehensive mitochondrial deoxyribo nucleic acid mutational analysis in patients with congenital heart disease.


Subject(s)
Cardiomyopathies/genetics , DNA, Mitochondrial/genetics , Heart Defects, Congenital/genetics , Mutation/genetics , Cardiomyopathies/congenital , Child, Preschool , Female , High-Throughput Nucleotide Sequencing/methods , Humans , Infant , Infant, Newborn , Male , Polymerase Chain Reaction , RNA, Ribosomal/genetics , RNA, Transfer/genetics , Sequence Analysis, DNA/methods , Turkey
3.
Cardiol Young ; 24(3): 531-3, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23735083

ABSTRACT

We report the case of a novel mitochondrial DNA mutation in the MT-ATP8 gene in an infant with tetralogy of Fallot. Next-generation sequencing was applied to sequence whole mitochondrial DNA of the patient. A known Leber's hereditary optic neuropathy-associated mutation (G9804A), a heteroplasmic T7501C mutation (17%), and a novel C8481 T Pro > Leu missense mutation in the MT-ATP8 gene was identified.


Subject(s)
Adenosine Triphosphatases/genetics , DNA, Mitochondrial/genetics , Mutation , Phospholipid Transfer Proteins/genetics , Tetralogy of Fallot/genetics , Humans , Infant , Male
4.
J Card Surg ; 26(3): 286-7, 2011 May.
Article in English | MEDLINE | ID: mdl-21585534

ABSTRACT

Cardiac myxomas are most commonly found within the left atrium. We now report a patient presenting with dyspnea, palpitation, and chest pain who was found to have myxoma arising from the pulmonary valve commissure. Urgent surgical treatment is curative and warranted for these lesions, in order to prevent outflow obstruction and thromboembolic phenomena.


Subject(s)
Myxoma/diagnosis , Pulmonary Artery , Vascular Neoplasms/diagnosis , Vascular Surgical Procedures/methods , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Middle Aged , Myxoma/surgery , Radiography, Thoracic , Vascular Neoplasms/surgery
5.
J Pediatr Surg ; 45(11): 2241-3, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21034952

ABSTRACT

Primary intrabronchial neurilemmas, also called schwannomas, are extremely rare tumors that originate from Schwann cells. We report a case of intrabronchial schwannoma arising in the left main bronchus in an 8-year-old child. The diagnosis was made by bronchofiberscopic biopsy. Although the tumor was benign, the patient was subjected to left pneumonectomy because of destruction of the pulmonary parenchyma distal to the obstruction. The diagnosis of intrabronchial schwannoma was supported pathologically with characteristic findings on Antoni A and Antoni B areas. This case is unique in that it is the youngest case in the literature.


Subject(s)
Bronchial Neoplasms/diagnosis , Neurilemmoma/diagnosis , Pneumonectomy/methods , Biopsy , Bronchial Neoplasms/surgery , Bronchoscopy , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Neurilemmoma/surgery , Radiography, Thoracic , Tomography, X-Ray Computed
6.
J Card Surg ; 24(4): 397-403, 2009.
Article in English | MEDLINE | ID: mdl-19583607

ABSTRACT

BACKGROUND: Cerebral injury is a well-known complication after cardiac surgery with cardiopulmonary bypass (CPB), especially in adult patients. Specific biochemical markers like neuron-specific enolase (NSE) and S-100beta protein were developed previously for early detecting neuronal damage after CPB. Corticosteroids are shown to reduce multisystemic deleterious effects of cardiopulmonary bypass due to their anti-inflammatory characteristics. The aim of this study is to demonstrate the decrease of serum neuron-specific enolase levels in patients who received corticosteroids before CPB. METHODS: Thirty patients scheduled for elective coronary bypass surgery were included in the study. Patients were divided randomly into two groups as the control group (n = 15) who underwent a standard coronary bypass surgery without any additional medication and the study group (n = 15) who received 1 gm of methylprednisolone before CPB. Blood samples for analysis of serum NSE, interleukin-6 (IL-6), and IL-10 were drawn before CPB, 4 and 24 hours after the end of extracorporeal circulation. RESULTS: Serum cytokine and NSE levels were significantly increased after CPB above their normal range in both groups. In the study group, IL-6 and NSE levels were significantly reduced while IL-10 levels were much higher after CPB. High NSE levels significantly correlated with IL-6 levels in the control group. CONCLUSION: The lower levels of NSE in patients who received methylprednisolone may suggest that corticosteroids might be useful in decreasing possible neuronal damage during heart surgery. However, we were not able to demonstrate an adverse neurological outcome.


Subject(s)
Coronary Artery Bypass , Methylprednisolone/therapeutic use , Neuroprotective Agents/therapeutic use , Phosphopyruvate Hydratase/blood , Premedication , Biomarkers/blood , Brain Injuries/blood , Brain Injuries/prevention & control , Female , Humans , Interleukin-10/blood , Interleukin-6/blood , Male , Middle Aged
7.
Acta Cardiol ; 63(5): 585-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19014001

ABSTRACT

BACKGROUND: Down's syndrome (DS) is the most common chromosomal abnormality due to a trisomy of chromosome 21 commonly associated with congenital heart defects (CHDs). This study aimed to evaluate the frequency and types of CHD patterns in Turkish children with DS. METHOD: The data relate to paediatric patients with DS who underwent cardiologic screening between 1994 and 2007 and were reviewed in our Paediatric Cardiology unit. RESULTS: Four hundred and twenty-one out of the 1042 paediatric patients with DS studied over a 13-year period had associated CHD. Of these, 320 (77.6%) had a single cardiac lesion, while the remaining 92 patients (22.4%) had multiple defects. The most common single defect was an atrioventricular septal defect (AVSD) found in 141 patients (34.2%), followed by 69 patients (16.7%) showing secundum type atrial septal defect, and ventricular septal defect in 68 patients (16.5%). AVSDs were the leading type, isolated or combined with other cardiac anomalies with an overall occurrence of 19.8% of paediatric patients with DS, and 49.2% of paediatric patients with both DS and CHD. CONCLUSION: This is the first study concerning the frequency and type of CHD observed in Turkish children with DS. The high frequency of AVSD in Turkish children with DS implied that early screening for CHDs by echocardiography is crucial. The correction of AVSDs in paediatric patients with DS should be performed in the first 6 months of life to avoid irreversible haemodynamic consequences of the defect.


Subject(s)
Down Syndrome/complications , Down Syndrome/epidemiology , Heart Defects, Congenital/epidemiology , Adolescent , Child , Child, Preschool , Down Syndrome/diagnosis , Down Syndrome/diagnostic imaging , Female , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/diagnostic imaging , Heart Septal Defects, Atrial/diagnostic imaging , Heart Septal Defects, Atrial/epidemiology , Heart Septal Defects, Ventricular/diagnostic imaging , Heart Septal Defects, Ventricular/epidemiology , Humans , Infant , Infant, Newborn , Male , Mass Screening , Retrospective Studies , Risk Factors , Turkey/epidemiology , Ultrasonography
8.
J Thromb Thrombolysis ; 25(3): 297-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-17589806

ABSTRACT

Pulmonary embolus sourced by right atrial thrombus trapped in a patent foramen ovale is an unusual, rare condition. Thus in suspicion of massive pulmonary thromboembolus, echocardiographic examination carries great importance evaluate right ventricular functions and diagnose right sided intracardiac thrombus. We report a 76-year-old female with massive pulmonary embolism caused by a gigantic thrombus trapped in a patent foramen ovale. The echocardiography was the diagnostic procedure to display the source of the thromboembolism and urgent cardiac surgery was successful and life-saving treatment in this case.


Subject(s)
Echocardiography, Transesophageal , Foramen Ovale, Patent/diagnostic imaging , Heart Diseases/diagnostic imaging , Pulmonary Embolism/etiology , Thrombosis/diagnostic imaging , Aged , Cardiac Surgical Procedures , Female , Foramen Ovale, Patent/complications , Foramen Ovale, Patent/surgery , Heart Atria/diagnostic imaging , Heart Diseases/complications , Heart Diseases/surgery , Humans , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/surgery , Thrombosis/complications , Thrombosis/surgery , Treatment Outcome
9.
Cardiol Young ; 17(4): 445-7, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17594736

ABSTRACT

We describe a male infant, seen at the age of 10 days, with a very rare form of vascular ring. The aortic arch was left-sided, but the aorta descended on the right, with a right-sided persistently patent arterial duct associated with interruption of the aortic arch and presence of Abbott's artery. We performed end-to-side anastomosis of the descending aorta to the ascending aorta, divided the Abbott's artery and the right-sided arterial duct, and banded the pulmonary trunk. Despite our best efforts, the patient died on the eighth day after the surgical intervention.


Subject(s)
Aorta, Thoracic/abnormalities , Coronary Vessel Anomalies/diagnosis , Ductus Arteriosus, Patent/diagnosis , Coronary Vessel Anomalies/surgery , Ductus Arteriosus, Patent/surgery , Fatal Outcome , Humans , Infant, Newborn , Male
10.
J Card Surg ; 21(6): 585-6, 2006.
Article in English | MEDLINE | ID: mdl-17073958

ABSTRACT

Pleural effusions after modified Fontan operations are unpredictable and contribute significantly to the morbidity and prolonged hospitalization. Chemical pleurodesis is widely performed in adults for malignant pleural effusions, but has found less chance of usage for benign cases or the cases with unidentified etiology. Although it is a safe and easily performed procedure, the use of bleomycin for the treatment of pleural effusions in the pediatric age population has been rarely reported in the literature. In this manuscript, we present a case with prolonged pleural effusion after extracardiac Fontan operation, which was successfully treated with bleomycin pleurodesis.


Subject(s)
Bleomycin/administration & dosage , Fontan Procedure/adverse effects , Pleural Effusion/etiology , Pleurodesis , Pulmonary Valve Stenosis/complications , Tricuspid Atresia/surgery , Child , Diagnosis, Differential , Female , Humans , Pleural Effusion/therapy , Tricuspid Atresia/complications
11.
Acta Cardiol ; 61(3): 285-8, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16869448

ABSTRACT

Atrial myxomas are the most commonly encountered tumours of the heart and can present at different ages with different clinical symptoms. They are one of the curable tumours of the heart. Appropriate surgical treatment and surgery must be performed with great precautions in order to prevent fatal systemic embolizations. In this retrospective study we will present our experience of 14 years, between 1990 and 2004, in 27 patients who had been operated for cardiac myxomas. Diagnosis of the myxomas were made by echocardiography in all cases. Surgical approach to the tumour was biatrial in nine, left atrial in II, and transseptal in seven patients. Associated procedures included coronary artery bypass grafting in one, mitral valve repair with tricuspid annuloplasty in two patients, mitral valve replacement in one and bilateral femoral embolectomy in one patient. One hospital mortality occurred as a result of multiorgan failure in a patient with peripheral embolization. None of the patients required recurrent operation, however, mitral valve insufficiency was surgically corrected in one patient.


Subject(s)
Heart Atria/surgery , Heart Neoplasms/surgery , Myxoma/surgery , Adolescent , Adult , Aged , Child , Echocardiography , Embolism/etiology , Embolism/mortality , Female , Follow-Up Studies , Heart Atria/diagnostic imaging , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/mortality , Hospital Mortality , Humans , Male , Middle Aged , Multiple Organ Failure/etiology , Multiple Organ Failure/mortality , Myxoma/diagnostic imaging , Myxoma/mortality , Outcome Assessment, Health Care , Postoperative Complications/etiology , Postoperative Complications/mortality , Retrospective Studies
12.
Turk J Pediatr ; 48(1): 8-12, 2006.
Article in English | MEDLINE | ID: mdl-16562779

ABSTRACT

We reviewed all cases of primary pediatric mediastinal masses diagnosed and treated over a 24-year period. In this study, out of 187 primary mediastinal mass cases diagnosed between 1980 and 2004 in Istanbul University Istanbul Faculty of Medicine, Cardiovascular Surgery Department, 37 pediatric primary mediastinal mass cases were retrospectively evaluated according to age, sex, symptoms, diagnostic procedure, anatomical location, surgical treatment, histopathological evaluation and postoperative adjuvant therapy. The patients ranged in age from 2 months to 15 years at the time of diagnosis, with a mean age of 8 years. There were 24 benign (64.8%) and 13 malignant (35.2%) tumors. The cases were lymphoma (27%), neurogenic tumors (21.6%), cystic lesions (18.9%), germ cell tumors (13.5%), thymic lesions (10.8%) and cardiac tumors (8.1%). Complete and partial resections of the tumor were the surgical procedures performed in 24 patients (64.8%) and 3 patients (8.1%), respectively. The three patients with a malignant tumor, in whom the entire mass could not be removed, received chemotherapy and radiation after surgery. In 10 patients with lymphoma, surgery was not a part of treatment and they received medical and radiation therapy after the establishment of the definitive diagnosis. All patients survived and were discharged from the hospital. Except for the cases with lyphoma, all patients are now free of recurrent disease. Compared to adults, children had more lymphomas and neurogenic tumors. Primary pediatric mediastinal malignancies are relatively common in infants and children. Lymphoma, neurogenic tumors and cystic lesions predominated. These differences between the age groups should also be considered when dealing with a mediastinal mass.


Subject(s)
Mediastinal Neoplasms , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Mediastinal Neoplasms/diagnosis , Mediastinal Neoplasms/epidemiology , Mediastinal Neoplasms/surgery , Retrospective Studies , Turkey/epidemiology
13.
J Cardiothorac Vasc Anesth ; 20(1): 43-7, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16458212

ABSTRACT

OBJECTIVE: The determination of postoperative course after cardiac surgery has always been a challenging issue. It is more sophisticated in the pediatric age group. The aim of this investigation was to identify whether increased concentrations of lactate in arterial blood has a predictive value for postoperative morbidity and mortality after heart surgery. METHODS: From May 2002 to June 2003, 60 infants operated on at the authors' institution were included in this prospective study. The patients were divided into 2 groups according to their respective postoperative serum lactate values. After the stabilization period in the intensive care unit (first 3 hours postoperatively), samples for serum lactate were obtained from arterial blood at 3 (t1), 6 (t2), and 12 hours (t3) postoperatively. The patients were subdivided into 2 groups according to their respective mean serum lactate values. A value of 4.8 mmol/L (3 times the normal upper limit) was chosen as a threshold for serum lactate. The patients with a mean value of greater than 4.8 mmol/L (group 1) were compared with the remaining group of patients (group 2). The relationship between serum mean lactate level and intraoperative and postoperative clinical variables was evaluated. RESULTS: Among the patients in this study, 26 (43.3%) had a serum mean lactate level more than 4.8 mmol/L and 34 (56.7%) had a level of 4.8 mmol/L or less. Age, aortic cross-clamping time, cardiopulmonary bypass time, and the lowest hematocrit during cardiopulmonary bypass were significant variables that influenced the postoperative serum mean lactate level. Six patients died in the postoperative period and 54 infants survived. The hospital mortality was significantly higher in group 1 than in group 2 (19.0% v 2.9%; p = 0.037, kappa = 0.179). Multivariate analysis revealed that serum mean lactate level correlated significantly with inotrope score, intubation time, and intensive care unit stay. CONCLUSIONS: Blood lactate concentration of 4.8 mmol/L or higher during the early postoperative hours identifies a group of patients with increased risk of postoperative morbidity and mortality.


Subject(s)
Cardiac Surgical Procedures/mortality , Lactic Acid/blood , Child, Preschool , Humans , Multivariate Analysis , Postoperative Period , Prognosis , Regression Analysis
14.
Cardiol Young ; 15(6): 621-6, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16297257

ABSTRACT

OBJECTIVE: Infective endocarditis is uncommon condition, with a high degree of morbidity and mortality. It is less common in children, albeit tending to be associated with congenital cardiac malformations. We describe our experience of the need for surgical treatment in children with infective endocarditis. PATIENTS AND METHODS: We analyzed retrospectively the records of 9 children aged below 16 years seen between May 2003 and March 2005 with infective endocarditis, reviewing the demographic details, clinical presentation, microbiological and echocardiographic data, operative findings, and outcome. RESULTS: Apart from pre-existing renal insufficiency in 1 patient, congenital cardiac malformations were the predisposing factors. Blood cultures were positive in 3, but remained negative in the other 6 patients. The indications for surgical treatment included uncontrolled sepsis, congestive heart failure, recurrent endocarditis, patch or graft dehiscence, and pseudoaneursymal formation. Death due to uncontrolled sepsis resulting in multiorgan failure occurred in 1 patient, who had tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. Another patient died late postoperatively due to cardiac failure after relapse of the endocarditis in the setting of negative blood cultures. CONCLUSION: Despite advances in antimicrobial therapy, diagnosis, and measures of treatment for infective endocarditis, complications continue to be responsible for substantial morbidity and mortality. Since blood cultures are frequently negative, clinical and echocardiographic findings should be the major determinants of strategies used for treatment. We believe that our small series of patients seen over the past two years in which surgical treatment was performed will be helpful in guiding the clinical perspectives for children with infective endocarditis.


Subject(s)
Endocarditis, Bacterial/surgery , Adolescent , Child , Child, Preschool , Echocardiography , Endocarditis, Bacterial/diagnostic imaging , Female , Heart Defects, Congenital/diagnostic imaging , Heart Defects, Congenital/surgery , Humans , Infant , Male , Retrospective Studies , Treatment Outcome
15.
Cardiol Young ; 15(3): 322-3, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15865841

ABSTRACT

Idiopathic aneurysms of the inferior caval vein are uncommon in children and adults. We describe a 14 year old boy with a saccular aneurysm of the inferior caval vein, in whom no surgical intervention was required to repair the aneurysm. The patient is being followed-up periodically for the evaluation of any increase in the diameter of the inferior caval vein.


Subject(s)
Aneurysm/diagnostic imaging , Vena Cava, Inferior/diagnostic imaging , Adolescent , Angiography/methods , Follow-Up Studies , Humans , Male , Tomography, X-Ray Computed/methods
16.
Ann Thorac Surg ; 79(4): 1402-5, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15797093

ABSTRACT

We report a case of primary cardiac epithelioid hemangioendothelioma arising from the right atrium of a 2-month-old infant. The tumor was found incidentally during exploratory sternotomy for recurrent pericardial effusion. This case represents a very rare situation, because this is the youngest patient found in relevant literature, and because it involves extensive infiltration by the tumor without any development of intracardiac mass appearance.


Subject(s)
Heart Neoplasms/surgery , Hemangioendothelioma, Epithelioid/surgery , Adult , Female , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology , Hemangioendothelioma, Epithelioid/diagnostic imaging , Hemangioendothelioma, Epithelioid/pathology , Humans , Infant , Male , Pregnancy , Ultrasonography
17.
Scand Cardiovasc J ; 38(5): 307-11, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15513315

ABSTRACT

BACKGROUND: Systemic inflammatory response and capillary leak syndrome, caused by extracorporeal circulation, have negative effects on the function of vital organs during the postoperative period. Modified ultrafiltration (MUF) has been developed as an alternative method to reduce the detrimental effects of cardiopulmonary bypass. The aim of this prospective, randomized study is to analyze the effects of MUF in a pediatric population undergoing congenital cardiac surgery. METHODS: Twenty-seven patients who underwent open-heart surgery at our institution were included in this prospective study. They were randomized into two groups as follows: Group I (n=14) of conventional ultrafiltration during bypass and Group II (n=13) receiving both conventional and modified ultrafiltration during and after the cessation of the bypass, respectively. The amount of prime volume, postoperative chest drain loss, transfusion requirements, hemodynamical parameters, duration of mechanical ventilatory support, and length of intensive care unit stay were compared between the two groups. During the postoperative period, the concentrations of hematological, biochemical and inflammatory parameters were also compared by analyzing the blood samples obtained at various time points. RESULTS: MUF resulted in a significant increase in hemoglobin, hematocrit and platelet levels, and significantly reduced the amount of chest tube output and transfused blood and blood products. MUF also shortened the duration of postoperative mechanical ventilatory support, length of the intensive care unit stay and improved postoperative hemodynamical parameters. During the early postoperative hours, IL-8 is significantly reduced in patients undergoing MUF, however, the concentrations of IL-8 were similar in both groups at the end of 24 h. CONCLUSIONS: MUF decreases the duration of mechanical ventilatory support, the length of intensive care unit stay, the need for blood transfusion and improves postoperative hemodynamics. It is associated with increased levels of hemoglobin, hematocrit and platelets. We can conclude that MUF attenuates the inflammatory response by decreasing the levels of inflammatory mediators.


Subject(s)
Cardiopulmonary Bypass/methods , Heart Defects, Congenital/surgery , Hemofiltration/methods , Blood Pressure , Cardiopulmonary Bypass/adverse effects , Female , Humans , Infant , Interleukin-8/blood , Male , Postoperative Period , Prospective Studies , Treatment Outcome
19.
Arch Gynecol Obstet ; 269(3): 211-3, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15069929

ABSTRACT

INTRODUCTION: Conjoined twins occur in one 50-200,000 live births and approximately 75% of all cases are thoracopagus twins. Parapagus conjoined twins are rare and are not included in many review articles. CASE REPORT: The cardiovascular system of a male parapagus (dicephalus, tetrabrachius, dipus) conjoined twins was studied. Twin B had bilateral bilobed lungs and a normal heart, while bilateral trilobed lungs and right isomerism was found in twin A. They shared a diaphragm and an abdominal cavity. There were two complete heads on two necks, two thoraxes, one abdomen, four arms, two legs, two complete vertebral columns, a single pelvis, and severe cardiac abnormalities.


Subject(s)
Heart Defects, Congenital/diagnostic imaging , Prenatal Diagnosis , Twins, Conjoined/pathology , Abnormalities, Multiple/diagnostic imaging , Abnormalities, Multiple/embryology , Abnormalities, Multiple/pathology , Abortion, Therapeutic , Adult , Diagnosis, Differential , Female , Heart Defects, Congenital/pathology , Humans , Male , Pregnancy , Pregnancy Trimester, Second , Radiography
20.
Surg Today ; 33(9): 666-70, 2003.
Article in English | MEDLINE | ID: mdl-12928842

ABSTRACT

PURPOSE: To clarify the factors that influence improvement and remission after thymectomy for patients with nonthymomatous myasthenia gravis (MG). METHODS: We retrospectively reviewed 204 patients with nonthymomatous MG who underwent thymectomy and anterior mediastinal dissection through a partial median sternotomy, between 1980 and 2001, and examined whether age, sex, preoperative classification, and duration of symptoms influenced their prognosis. RESULTS: There was no perioperative or hospital mortality. The mean follow-up period was 7.2 +/- 1.2 years, with early and late postoperative remission rates of 44.6% and 73%, respectively. Seven patients died; two from pneumonia and five from causes unrelated to MG. Preoperative treatment and classification, duration of symptoms, age, and sex did not seem to have a significant influence on remission, but the response to thymectomy was greater in patients with thymic hyperplasia. Remission and improvement rates were significantly better at the end of the first year, with the same status found at the last follow-up. CONCLUSION: Thymectomy is an effective and highly curative method of treatment for patients. with MG. It provides excellent symptomatic improvement, which is enhanced over the long term.


Subject(s)
Myasthenia Gravis/surgery , Thymectomy , Adolescent , Adult , Age Factors , Child , Female , Humans , Male , Middle Aged , Myasthenia Gravis/pathology , Prognosis , Retrospective Studies , Sex Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...